Na Li, Ph.D., of Sino Biological discusses the potential of anti-idiotype (anti-ID) antibodies as therapeutic agents and the necessary experience, high-throughput production capabilities, manufacturing capacity, and analytical expertise that enables Sino Biological to rapidly develop custom anti-IDs.
.svg)
